PubMed · 2006 · 33 citations · 19 references
MedicineCardiologySurgeryCardiothoracic SurgeryClinical CardiologyInterventional CardiologyAcute Coronary Syndrome InterventionCardiovascular DiseaseCoronary AngioplastyCoronary Artery DiseaseIschemic Heart DiseaseStent PlacementComplications Of Stent PlacementCoronary StentingIn-stent ThrombosisManagement Of High-risk PatientsSerious Adverse EventsStent Patency AssessmentStent Thrombosis PreventionTitanium Nitride Coatings
AIMS: The aim of the Titan PORI Registry was to evaluate the safety and efficacy of a stainless steel stent coated with titanium nitride oxide (Titan(R), Hexacath, France) in routine clinical practice. METHODS AND RESULTS: We report a prospective single-centre experience in treating patients with the Titan(R) stent. All consecutive patients receiving Titan(R) stent(s) were enrolled. The choice of a stent was at the discretion of the operator with no exclusion criteria. The primary end point of the registry was Major Adverse Cardiac Events (MACE) at 6 and 9 months. A total of 210 lesions were treated in 193 enrolled patients (mean age 67+/-10; men 71%; diabetes 17%). Lesions were of type B in 64% and type C in 23%. The indications for PCI were unstable angina or non-Q-wave MI in 36% and acute STEMI in 30% of the patients. Mean reference diameter was 2.9+/-0.3 mm and mean lesion length 12.9+/-3.0 mm. Mean stent size was 2.98 mm (range 2-3.5 mm) and length 15.5 mm (range 7-28 mm). Stent delivery was successful in all cases (23% direct stenting). Complete follow-up of all 193 patients was obtained up to 9 months. There were no in-hospital or 30-day MACE observed. At 270 days, the MACE rate was 10.4% (MI 4.1%, cardiac death 0%, TVR 8.3%). There were no cases with stent thrombosis. CONCLUSION: These medium term data confirm good safety profile of Titan(R) stent even in high risk patients and complex coronary lesions in routine clinical use.
19
Patrick W. Serruys, Peter de Jaegere, Ferdinand Kiemeneij et al. · New England Journal of Medicine · 1994 · 4.5K citations · Full text
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
Gregg W. Stone, Stephen G. Ellis, David A. Cox et al. · New England Journal of Medicine · 2004 · 2.7K citations · Full text
Medicine, Cardiology, Surgery +14
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
Eugène McFadden, Eugenio Stabile, Evelyn Regar et al. · The Lancet · 2004 · 1.4K citations
Medicine, Cardiology, Pharmacology +16
Intracoronary Stenting and Angiographic Results
Adnan Kastrati, Julinda Mehilli, Josef Dirschinger et al. · Circulation · 2001 · 945 citations · Full text
Medicine, Cardiology, Surgery +17